Treatment of intractable narcolepsy with a monoamine oxidase inhibitor.
D000328:Adult; D002385:Cataplexy / Q000188:drug therapy; D002986:Clinical Trials as Topic; D004325:Dreams / Q000187:drug effects; D004487:Edema / Q000139:chemically induced; D004569:Electroencephalography; D004576:Electromyography; D004585:Electrooculography; D005260:Female; D006801:Humans; D007022:Hypotension / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D009290:Narcolepsy / Q000188:drug therapy*; D010624:Phenelzine / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D010919:Placebos; D012890:Sleep / Q000187:drug effects; D012895:Sleep, REM / Q000187:drug effects
D010919:Placebos; D010624:Phenelzine